Neil Klompas
Director/Board Member chez LIMINAL BIOSCIENCES INC.
Fortune : 186 541 $ au 31/03/2024
Profil
Neil A.
Klompas is an Independent Director at Liminal BioSciences, Inc., a Director at Ovensa, Inc., a Director at Canadian Gene Cure Foundation, and a Member at The Chartered Professional Accountants of British Columbia.
He was previously the Chief Operating Officer at Zymeworks BC, Inc. and Zymeworks, Inc., a Manager-Mergers & Acquisitions Transactions at KPMG LLP, and an Audit Manager at KPMG LLP (Canada).
He received an undergraduate degree from the University of British Columbia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZYMEWORKS INC.
0,03% | 11/10/2023 | 17 732 ( 0,03% ) | 186 541 $ | 31/03/2024 |
Postes actifs de Neil Klompas
| Sociétés | Poste | Début |
|---|---|---|
| LIMINAL BIOSCIENCES INC. | Director/Board Member | 01/05/2019 |
The Chartered Professional Accountants of British Columbia
 The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services The Chartered Professional Accountants of British Columbia is an association of accountants based in Vancouver, Canada. and has subsidiaries in Australia. The Canadian company operates as an association of accountants. The CEO of the private company is Lori Mathison. | Corporate Officer/Principal | - |
| Canadian Gene Cure Foundation | Director/Board Member | - |
Ovensa, Inc.
 Ovensa, Inc. Internet Software/ServicesTechnology Services Ovensa, Inc. operates as a preclinical stage biotechnology company. It focuses in oncology and neurodegenerative diseases. The company is headquartered in Aurora, Canada. | Director/Board Member | 01/01/2017 |
Anciens postes connus de Neil Klompas
| Sociétés | Poste | Fin |
|---|---|---|
| ZYMEWORKS INC. | President | 30/06/2023 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Director of Finance/CFO | 24/02/2022 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2007 |
KPMG LLP (Canada)
 KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of accounting, tax preparation, and advisory services. It also offers auditing, internal audit, regulatory and compliance, corporate recovery, and forensic accounting, and risk management services. The company was founded in 1869 and is headquartered in Toronto, Canada. | Comptroller/Controller/Auditor | 01/01/2005 |
Formation de Neil Klompas
| University of British Columbia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LIMINAL BIOSCIENCES INC. | Health Technology |
| ZYMEWORKS INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
KPMG LLP (Canada)
KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of accounting, tax preparation, and advisory services. It also offers auditing, internal audit, regulatory and compliance, corporate recovery, and forensic accounting, and risk management services. The company was founded in 1869 and is headquartered in Toronto, Canada. | Commercial Services |
The Chartered Professional Accountants of British Columbia
The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services The Chartered Professional Accountants of British Columbia is an association of accountants based in Vancouver, Canada. and has subsidiaries in Australia. The Canadian company operates as an association of accountants. The CEO of the private company is Lori Mathison. | Commercial Services |
Ovensa, Inc.
Ovensa, Inc. Internet Software/ServicesTechnology Services Ovensa, Inc. operates as a preclinical stage biotechnology company. It focuses in oncology and neurodegenerative diseases. The company is headquartered in Aurora, Canada. | Technology Services |
| Canadian Gene Cure Foundation |
